
GC32735
CT7001 hydrochloride
Also listed as Samuraciclib hydrochloride (ICEC0942 hydrochloride)
CT7001 hydrochloride (ICEC0942 hydrochloride) (CT7001 hydrochloride) is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM· CT7001 hydrochloride (ICEC0942 hydrochloride) displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively· CT7001 hydrochloride (ICEC0942 hydrochloride) inhibits the growth of breast cancer cell lines with GI50 values between 0·2-0·3 μM· CT7001 hydrochloride (ICEC0942 hydrochloride) has anti-tumor effects
- CAS number
- 1805789-54-1
- Molecular weight
- 430.97
- Formula
- C22H31ClN6O
- Solubility
- DMSO : ≥ 62·5 mg/mL (145·02 mM)
- InChIKey
- YMNPLAHCOLEZJE-ZFNKBKEPSA-N
- Catalogue number
- GC32735
- Brand
- GLPBIO
Computed properties PubChem CID 91844732 · TPSA 86.5 Ų · H-bond donors 5 · H-bond acceptors 6
- TPSA
- 86.5 Ų
- H-bond donors
- 5
- H-bond acceptors
- 6
- Rotatable bonds
- 7
- Heavy atoms
- 30
SMILES CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O.Cl
Computed descriptors from PubChem (CID 91844732), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il